ES506213A0 - Procedimiento para preparar derivados metilolados de cefale-xina - Google Patents
Procedimiento para preparar derivados metilolados de cefale-xinaInfo
- Publication number
- ES506213A0 ES506213A0 ES506213A ES506213A ES506213A0 ES 506213 A0 ES506213 A0 ES 506213A0 ES 506213 A ES506213 A ES 506213A ES 506213 A ES506213 A ES 506213A ES 506213 A0 ES506213 A0 ES 506213A0
- Authority
- ES
- Spain
- Prior art keywords
- cefale
- xina
- procedure
- methylated derivatives
- preparing methylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT25267/80A IT1195762B (it) | 1980-10-13 | 1980-10-13 | Derivati idrosolubili della cefalexina e procedimento per la loro produzione |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8206533A1 ES8206533A1 (es) | 1982-08-16 |
ES506213A0 true ES506213A0 (es) | 1982-08-16 |
Family
ID=11216176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES506213A Granted ES506213A0 (es) | 1980-10-13 | 1981-10-13 | Procedimiento para preparar derivados metilolados de cefale-xina |
Country Status (17)
Country | Link |
---|---|
US (1) | US4471115A (es) |
EP (1) | EP0049928B1 (es) |
JP (1) | JPS5767583A (es) |
KR (1) | KR880000691B1 (es) |
AR (1) | AR229035A1 (es) |
AT (1) | ATE35813T1 (es) |
AU (1) | AU548333B2 (es) |
BE (1) | BE890718A (es) |
CA (1) | CA1181741A (es) |
DE (1) | DE3176811D1 (es) |
DK (1) | DK451281A (es) |
ES (1) | ES506213A0 (es) |
FR (1) | FR2491927B1 (es) |
IT (1) | IT1195762B (es) |
NO (1) | NO813433L (es) |
PT (1) | PT73807B (es) |
YU (1) | YU246381A (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102058853B1 (ko) * | 2018-02-28 | 2019-12-24 | 브릿지바이오테라퓨틱스(주) | 지질화 펩타이드의 수용성 염과 이의 제조 방법 및 용도 |
CA3094295A1 (en) * | 2018-03-29 | 2019-10-03 | S.I.S. Shulov Innovative Science Ltd. | Pharmaceutical compositions for inhibiting inflammatory cytokines |
KR102104507B1 (ko) * | 2019-08-23 | 2020-04-24 | 브릿지바이오테라퓨틱스(주) | 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1265315A (es) * | 1968-04-05 | 1972-03-01 | Glaxo Lab Ltd | |
BE786924A (fr) * | 1971-07-28 | 1973-01-29 | Squibb & Sons Inc | Antibiotiques, leur preparation et leurs utilisations therapeutiques |
US3796709A (en) * | 1971-11-19 | 1974-03-12 | Squibb & Sons Inc | (alpha-cyanamino)acetamidocephalosporins |
BE792229A (fr) * | 1971-12-03 | 1973-06-01 | Bristol Myers Co | Agents antibacteriens heterocycliques azotes et procede pour les preparer |
US3880842A (en) * | 1972-05-30 | 1975-04-29 | Squibb & Sons Inc | Cephalosporin derivatives |
US3988326A (en) * | 1974-02-22 | 1976-10-26 | Meiji Seika Kaisha, Ltd. | Process for N-acylation of 7 amino cephem compounds |
-
1980
- 1980-10-13 IT IT25267/80A patent/IT1195762B/it active
-
1981
- 1981-04-17 JP JP56057257A patent/JPS5767583A/ja active Pending
- 1981-10-06 AT AT81201107T patent/ATE35813T1/de not_active IP Right Cessation
- 1981-10-06 DE DE8181201107T patent/DE3176811D1/de not_active Expired
- 1981-10-06 EP EP81201107A patent/EP0049928B1/en not_active Expired
- 1981-10-12 DK DK451281A patent/DK451281A/da not_active Application Discontinuation
- 1981-10-12 NO NO813433A patent/NO813433L/no unknown
- 1981-10-12 AU AU76247/81A patent/AU548333B2/en not_active Ceased
- 1981-10-12 PT PT73807A patent/PT73807B/pt unknown
- 1981-10-12 FR FR8119156A patent/FR2491927B1/fr not_active Expired
- 1981-10-13 YU YU02463/81A patent/YU246381A/xx unknown
- 1981-10-13 ES ES506213A patent/ES506213A0/es active Granted
- 1981-10-13 AR AR287074A patent/AR229035A1/es active
- 1981-10-13 BE BE0/206233A patent/BE890718A/fr not_active IP Right Cessation
- 1981-10-13 CA CA000387814A patent/CA1181741A/en not_active Expired
- 1981-10-13 KR KR1019810003864A patent/KR880000691B1/ko active
-
1982
- 1982-12-22 US US06/452,159 patent/US4471115A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR830007681A (ko) | 1983-11-04 |
AU548333B2 (en) | 1985-12-05 |
ATE35813T1 (de) | 1988-08-15 |
ES8206533A1 (es) | 1982-08-16 |
IT1195762B (it) | 1988-10-27 |
YU246381A (en) | 1983-10-31 |
KR880000691B1 (ko) | 1988-04-23 |
AU7624781A (en) | 1982-04-22 |
EP0049928A3 (en) | 1983-04-06 |
AR229035A1 (es) | 1983-05-31 |
FR2491927A1 (fr) | 1982-04-16 |
DK451281A (da) | 1982-04-14 |
BE890718A (fr) | 1982-02-01 |
CA1181741A (en) | 1985-01-29 |
NO813433L (no) | 1982-04-14 |
JPS5767583A (en) | 1982-04-24 |
US4471115A (en) | 1984-09-11 |
PT73807A (fr) | 1981-11-01 |
FR2491927B1 (fr) | 1985-07-12 |
IT8025267A0 (it) | 1980-10-13 |
EP0049928B1 (en) | 1988-07-20 |
EP0049928A2 (en) | 1982-04-21 |
DE3176811D1 (en) | 1988-08-25 |
PT73807B (fr) | 1983-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES532765A0 (es) | Procedimiento para preparar derivados de 3-bencilidenalcanfor | |
ES526381A0 (es) | Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol | |
ES502276A0 (es) | Procedimiento para preparar derivados de piridoxina | |
ES505898A0 (es) | Procedimiento para preparar derivados de pirimidona | |
AR227906A1 (es) | Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina | |
ES522786A0 (es) | Procedimiento para preparar derivados de piperacina. | |
ES501535A0 (es) | Procedimiento para la preparacion de derivados de alquilfos-fonito | |
AR231289A1 (es) | Procedimiento para preparar derivados de quinolil-4-1-piperidilo-4-2-etanol o quinolil-4-1-piperidil-4-3-propanol | |
MX6752E (es) | Procedimiento para preparar derivados de carboestirilos | |
ES500796A0 (es) | Procedimiento para preparar derivados de pirimidona | |
ES503407A0 (es) | Procedimiento para la preparacion de derivados de pirimidina | |
ES499729A0 (es) | Procedimiento para la preparacion de derivados de fenoxi- aminopropanol | |
MX157614A (es) | Procedimiento para preparar derivados de isohexido | |
ES501736A0 (es) | Procedimiento para la preparacion de derivados de 2-guanidi-notiazol | |
ES504787A0 (es) | Procedimiento para la obtencion de derivados de diaril-imi- dazol | |
ES502649A0 (es) | Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos | |
ES500892A0 (es) | Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano | |
ES499421A0 (es) | Procedimiento para preparar derivados de indano | |
ES515567A0 (es) | Procedimiento para preparar derivados de fenantreno. | |
ES505206A0 (es) | Procedimiento para la obtencion de derivados de 1-azolil-bu-tano fluorados | |
AR229509A1 (es) | Procedimiento para preparar derivados de 2-halogeno-acetanilidas | |
ES506213A0 (es) | Procedimiento para preparar derivados metilolados de cefale-xina | |
ES505576A0 (es) | Procedimiento para la preparacion de derivados de 7-oxopros-taciclina | |
ES504681A0 (es) | Procedimiento para preparar derivados de 11- hidroxi-13 oxa-prostaglandina. | |
AR227341A1 (es) | Procedimiento para preparar derivados de bis-aminometil-antraquinona |